Open Access. Powered by Scholars. Published by Universities.®
Pharmacoeconomics and Pharmaceutical Economics Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Public Health (4)
- Epidemiology (3)
- Diseases (2)
- Health Services Research (2)
- Pharmacy Administration, Policy and Regulation (2)
-
- Alternative and Complementary Medicine (1)
- Artificial Intelligence and Robotics (1)
- Clinical Psychology (1)
- Computer Sciences (1)
- Data Science (1)
- Health Services Administration (1)
- Medical Specialties (1)
- Mental Disorders (1)
- Mental and Social Health (1)
- Musculoskeletal Diseases (1)
- Neoplasms (1)
- Oncology (1)
- Pain Management (1)
- Palliative Care (1)
- Physical Sciences and Mathematics (1)
- Preventive Medicine (1)
- Psychiatric and Mental Health (1)
- Psychiatry and Psychology (1)
- Psychology (1)
- Social and Behavioral Sciences (1)
- Keyword
-
- Machine learning (2)
- Alzheimer’s disease and related dementia (1)
- Annual wellness Visit (1)
- Antidepressants (1)
- Autoimmune diseases (1)
-
- Blood Pressure (1)
- CAM (1)
- Cancer (1)
- Cancer survivorship (1)
- Cardiovascular disease (1)
- Care Fragmentation (1)
- Chronic non-cancer pain conditions (1)
- Complementary and Alternative Medicines (1)
- Economic burden (1)
- Gastrointestinal disorders (1)
- Healthcare cost (1)
- Healthcare costs (1)
- Healthcare expenditures (1)
- Healthcare resource utilization (1)
- Immune checkpoint inhibitors (1)
- Inflammatory Chronic Conditions (1)
- Long-term opioid therapy (1)
- Low-value care (1)
- Machine Learning (1)
- Major depressive disorder (1)
- Melanoma (1)
- Metastatic melanoma (1)
- Multi-morbidity (1)
- Multimorbidity (1)
- NSAIDs (1)
Articles 1 - 5 of 5
Full-Text Articles in Pharmacoeconomics and Pharmaceutical Economics
Clinical And Economic Burden Of Inflammatory Chronic Conditions Among Adults In The United States: Evidence From Three Nationally Representative Surveys, Mohammad Ikram
Graduate Theses, Dissertations, and Problem Reports
A significant proportion of adults in the United States (US) suffer from various inflammatory chronic conditions (ICCs). They include a wide range of diseases such as diabetes, rheumatoid arthritis, asthma, and chronic obstructive pulmonary diseases. ICCs are not curable, and their management typically involves medications such as NSAIDs and corticosteroids. Recently, a whole health approach that places patients’ well-being at the center is increasingly being used for better management of ICCs. The whole health approach uses an integrated approach that includes multimodal management with complementary and alternative medicines (CAM) and prescription drugs. However, the use of CAM and prescription drugs …
Association Of Incident Cancer To Low-Value Care And Healthcare Cost Burden Among Elderly Medicare Beneficiaries, Chibuzo Iloabuchi
Association Of Incident Cancer To Low-Value Care And Healthcare Cost Burden Among Elderly Medicare Beneficiaries, Chibuzo Iloabuchi
Graduate Theses, Dissertations, and Problem Reports
In the United States (US), 25% of healthcare spending is considered wasteful because it is spent reimbursing low-value care. Low-value care is the utilization of healthcare services, medical tests, and procedures that have unclear or no clinical benefit to patients but still exposes them to risk. World-wide, low-value care imposes a significant economic burden on patients, payers, governments, and society. Cancer care among older adults > 65 years is one of the biggest drivers of healthcare expenditure in the US and accounts for nearly 40% of all spending, and low-value care among cancer patients is prevalent and contributes to the financial …
Multimorbidity, Immune Checkpoint Inhibitor Use, And Healthcare Expenditures Among Older Patients With Late-Stage Melanoma, Pragya Rai
Graduate Theses, Dissertations, and Problem Reports
With decades of unchanged cancer care with no added survival benefit, immune checkpoint inhibitors (ICI) changed the treatment landscape of late-stage melanoma in 2011. A key factor in determining the use of ICIs is the presence of pre-existing chronic conditions, which can influence the outcome. However, the prevalence of multimorbidity (defined as presence of two or more chronic conditions) among older patients with late-stage melanoma remains unknown. It also remains unknown if the presence of multimorbidity factors into the use of ICIs. Hospital-related factors associated with ICI use have been studied. Yet, patient-level factors, such as age, sex, marital status, …
Predictors Of Cardiovascular And Gastrointestinal Disorders, Inappropriate Nonsteroidal Anti-Inflammatory Drug Use, And Alzheimer’S Disease And Related Dementia In Older Adults With Osteoarthritis, Jayeshkumar Patel
Graduate Theses, Dissertations, and Problem Reports
Osteoarthritis (OA) is a degenerative arthritis affecting over 30 million Americans most of whom are over 65 years or older. Its clinical management is complicated by several disease- and treatment-specific factors. These include the co-occurrence of cardiovascular and gastrointestinal disorders (CV-GID), the inappropriate use of non-steroidal anti-inflammatory drugs (NSAID) to manage pain, and the risk of certain age-related chronic conditions like Alzheimer’s disease and related dementia (ADRD). Moreover, older adults with OA are at a higher risk of CV-GID, inappropriate NSAID use, and ADRD. Additionally, these factors can also affect one another in both a positive and a negative way. …
Predictors And Health Outcomes Of Treatment-Resistant Depression Among Adults With Chronic Non-Cancer Pain Conditions And Major Depressive Disorder, Drishti Shah
Graduate Theses, Dissertations, and Problem Reports
Understanding major depressive disorder (MDD) as a comorbidity in patients with chronic non-cancer pain conditions (CNPC) is of importance because of the high prevalence and well documented bi-directional relationship between MDD and pain. Furthermore, presence of CNPC among adults with MDD often reduces benefits of antidepressant therapy, thereby increasing the possibility of treatment resistance. Treatment-resistant depression (TRD) commonly defined as insufficient response to multiple antidepressant trials, often worsens depression and pain symptoms and can amplify the clinical and economic burden among adults with CNPC and MDD. Additionally, long-term opioid therapy (LTOT) may be prescribed at a higher rate to adults …